American Society of Hematology 2019 guidelines for immune thrombocytopenia
Columbia University Irving Medical Center · University of Oklahoma Health Sciences Center · +13 more institutions
Indexed incrossrefdoajpubmed
Abstract
Background
Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients.
Objective
These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in their decisions about the management of ITP.
Citation impact
1,315
total citations
- FWCI
- 82.17
- Percentile
- 100%
- References
- 225
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Guideline
- Rituximab
- Immune thrombocytopenia
- Intensive care medicine
- Clinical trial
- MEDLINE
- Randomized controlled trial
UN Sustainable Development Goals
- Peace, Justice and strong institutions
No related works found for this paper.